Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Day One Biopharmaceuticals Inc (NQ: DAWN ) 14.09 +0.41 (+3.00%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Day One Biopharmaceuticals Inc < Previous 1 2 3 4 Next > Bank of America Says Buy These 3 Stocks for a Double-Digit Rally August 14, 2024 Despite fears of a recession roiling the markets, analysts say these are the best stocks to buy with an average upside potential of 72%. Via InvestorPlace Topics Economy Exposures Economy Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday August 01, 2024 Via Benzinga DAWN Stock Earnings: Day One Biopharmaceutical Beats EPS, Beats Revenue for Q2 2024 July 30, 2024 DAWN stock results show that Day One Biopharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 25, 2024 Via Benzinga Analyst Ratings for Day One Biopharmaceutical November 07, 2023 Via Benzinga The Latest Analyst Ratings for Day One Biopharmaceutical September 12, 2023 Via Benzinga Where Day One Biopharmaceutical Stands With Analysts August 08, 2023 Via Benzinga Analyst Ratings for Day One Biopharmaceutical June 05, 2023 Via Benzinga Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal June 22, 2024 FutureGen Biopharm out-licensed global rights for its next-gen TL1A antibody to AbbVie in a $1.7 billion agreement. Also, MabCare Therapeutics out-licensed global rights for its ADC targeting... Via Talk Markets DAWN Stock Earnings: Day One Biopharmaceutical Misses EPS for Q1 2024 May 06, 2024 DAWN stock results show that Day One Biopharmaceutical missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Dow Up Over 340 Points As Stocks Snap Back October 30, 2023 The Dow Jones Industrial Average is building on this morning's gains, up 343 points at last look, while the S&P 500 and Nasdaq Composite sit firmly in the black as well. Via Talk Markets Topics Stocks Exposures US Equities Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday October 30, 2023 U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Why Day One Biopharmaceuticals Stock Is Trading Higher Premarket Today June 05, 2023 Via Benzinga 7 Analysts Have This to Say About Day One Biopharmaceutical May 18, 2023 Via Benzinga What 5 Analyst Ratings Have To Say About Day One Biopharmaceutical April 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session October 26, 2023 Via Benzinga $15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying October 23, 2023 Although U.S. stocks closed lower on Friday, there were a few notable insider trades. Via Benzinga $3.6 Bet On Asana? Check Out These 4 Stocks Insiders Are Buying June 13, 2023 Although US stocks closed higher on Monday, there were a few notable insider trades. Via Benzinga Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review June 09, 2023 The Nasdaq held near 52-week highs while small caps ramped up. Via Investor's Business Daily Why Shares of Day One Pharmaceuticals Are Up Monday June 05, 2023 The clinical-stage biotech released early trial news regarding its lead therapy candidate. Via The Motley Fool Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 05, 2023 Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Via Benzinga ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes June 05, 2023 ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference. Via Investor's Business Daily 12 Health Care Stocks Moving In Monday's Pre-Market Session June 05, 2023 Via Benzinga Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket June 05, 2023 Gainers Forza X1, Inc. (NASDAQ: FRZA) shares rose 85.6% to $2.32 in pre-market trading after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!' Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 05, 2023 It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Day One Biopharmaceuticals, ImmunoGen And Other Big Stocks Moving Higher In Monday's Pre-Market Session June 05, 2023 U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 25, 2023 Gainers Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023 April 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 25, 2023 Via Benzinga Lam Research, D.R. Horton, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday April 20, 2023 U.S. stocks traded lower, with the Dow Jones dropping around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.